You are here

necitumumab

Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate

Fierce Biotech

Sat, 08/29/15 - 08:56 am

non-small cell lung cancer

FDA support for Lilly cancer drug comes down to unmet needs vs side effects

BioPharma Dive

Sat, 07/11/15 - 10:34 am

non-small cell lung cancer

FDA panel says benefits outweigh risks for Lilly's lung-cancer drug

Medical Marketing and Media

Thu, 07/9/15 - 09:51 pm

advisory panels

Eli Lilly preps a familiar case for FDA review of a marginal cancer drug

Fierce Biotech

Mon, 07/6/15 - 12:16 pm

squamous non-small cell lung cancer

FDA panel to discuss Lilly's lung cancer drug approval

Yahoo/Reuters

Tue, 06/2/15 - 04:57 pm

advisory panels

Eli Lilly's necitumumab improves OS in Phase III study

The Fly on the Wall

Thu, 05/15/14 - 08:26 am

non-small cell lung cancer

Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue

Seeking Alpha

Sat, 08/31/13 - 11:20 am

Understanding the Massive Market Potential of Monoclonal Antibodies

Motley Fool

Wed, 08/28/13 - 04:53 pm

monoclonal antibodies

Bristol-Myers Squibb

Seattle Genetics

Eli Lilly Might Have A Blockbuster Cancer Drug

Seeking Alpha

Tue, 08/27/13 - 10:54 am

non-small cell lung cancer

Is This New Lung Cancer Treatment a Game Changer?

Motley Fool

Sat, 08/17/13 - 11:23 am

Cancer Breakthrough Could Mean Big Gains for This Pharma Giant

Yahoo/Street Authority

Wed, 08/14/13 - 09:13 am

non-small cell lung cancer

Eli Lilly Lung Cancer Drug Raises Patient Survival in Trial

Bloomberg

Tue, 08/13/13 - 10:48 am

Lilly, Bristol-Myers halt drug study enrollment

Yahoo/AP

Wed, 02/2/11 - 03:09 pm

Bristol-Myers Squibb